The House on July 19 approved, 367-58, the conference report for the FY2001 defense spending bill (H.R. 4576). The Senate may consider the conference report the week of July 24.
The final measure provides $175 million for peer-reviewed breast cancer research at the Department of Defense (DoD), the same amount as last year. The bill also level-funds ovarian cancer research at $12 million, the same amount provided in the Senate bill. The House-passed measure would have allocated $10 million for such research.
The final measure provides $6 million for osteoporosis research in FY2001. The Senate-passed bill would have provided $7.5 million, while the House-passed bill did not include a line item. Last year, Congress appropriated $4 million for osteoporosis research, but DoD added an additional $2.5 million, as requested by the President, bringing total funding for FY2000 to $6.5 million.
